Vitaspring Biomedical (VSBC) EBT Margin (2017 - 2022)
Vitaspring Biomedical (VSBC) reported EBT Margin of 23.60% for fiscal Q1 2023 (quarter ended Apr 30, 2022), down 10.01 percentage points from 33.61% a year earlier and down 17.08 percentage points from the prior quarter.
Powered by 
Analysis
Vitaspring Biomedical (VSBC) EBT Margin (2017 - 2022) Analysis & Trends
For FY2022 (ended Jan 31, 2022), Vitaspring Biomedical posted EBT Margin of 20.07%, up 191.46 percentage points from FY2021.
- EBT Margin has a four-year change of +59.34 percentage points (FY2018 to FY2022).
- By fiscal year, EBT Margin came in at -171.39% in FY2021 (-217.09 pp), 45.70% in FY2020 (+176.06 pp), -130.36% in FY2019 (-91.09 pp) and -39.27% in FY2018.
- Five-year quarterly EBT Margin spans a low of -17402.67% in fiscal Q3 2019 and a high of 2631.75% in fiscal Q4 2019.
- The high point for year-over-year EBT Margin in five years was fiscal Q4 2019 (a gain of 720.36 percentage points); the low point was fiscal Q3 2019 (a drop of 17396.48 percentage points).
- Per Business Quant data, the three fiscal quarters before Q1 2023 came in at 40.68% (Q4 2022), 68.73% (Q3 2022) and 18.04% (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Vitaspring Biomedical | 2.07 Mn | 2.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2022 | 23.60% |
| Jan 31, 2022 | 40.68% |
| Oct 31, 2021 | 68.73% |
| Jul 31, 2021 | 18.04% |
| Apr 30, 2021 | 33.61% |
| Jan 31, 2021 | -139.29% |
| Jan 31, 2020 | -141.62% |
| Apr 30, 2019 | -117.95% |
| Jan 31, 2019 | 2,631.75% |
| Oct 31, 2018 | -17,402.67% |
| Jul 31, 2018 | -598.45% |
| Apr 30, 2018 | 39.99% |
| Jan 31, 2018 | 1,911.39% |
| Oct 31, 2017 | -6.18% |
| Jul 31, 2017 | -23.36% |
| Apr 30, 2017 | 186.34% |
API Access
Vitaspring Biomedical EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=VSBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();